{"id":"https://openalex.org/W7148845708","doi":"https://doi.org/10.1158/1538-7445.am2026-5750","title":"Abstract 5750: Solid tumor cell-intrinsic function of PI3K\u03b4","display_name":"Abstract 5750: Solid tumor cell-intrinsic function of PI3K\u03b4","publication_year":2026,"publication_date":"2026-04-03","ids":{"openalex":"https://openalex.org/W7148845708","doi":"https://doi.org/10.1158/1538-7445.am2026-5750"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2026-5750","doi":"https://doi.org/10.1158/1538-7445.am2026-5750","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-5750","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071786017","display_name":"Sarah E. Conduit","orcid":"https://orcid.org/0000-0002-5075-8851","observed_orcids":["https://orcid.org/0000-0002-5075-8851"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah E. Conduit","raw_affiliation_strings":["1University College London (UCL), London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University College London (UCL), London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001381073","display_name":"Elena Lopez-Guadamillas","orcid":"https://orcid.org/0000-0002-4043-3551","observed_orcids":["https://orcid.org/0000-0002-4043-3551"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elena Lopez-Guadamillas","raw_affiliation_strings":["1University College London (UCL), London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University College London (UCL), London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115565607","display_name":"Daniele Morelli","orcid":"https://orcid.org/0000-0002-3714-6658","observed_orcids":["https://orcid.org/0000-0002-3714-6658"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniele Morelli","raw_affiliation_strings":["1University College London (UCL), London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University College London (UCL), London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Harriet Howard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Harriet Howard","raw_affiliation_strings":["1University College London (UCL), London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University College London (UCL), London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091361595","display_name":"Wayne P Pearce","orcid":"https://orcid.org/0000-0001-5407-4767","observed_orcids":["https://orcid.org/0000-0001-5407-4767"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Wayne Pearce","raw_affiliation_strings":["1University College London (UCL), London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University College London (UCL), London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044637749","display_name":"Cheryl L. Scudamore","orcid":"https://orcid.org/0000-0002-7101-1714","observed_orcids":["https://orcid.org/0000-0002-7101-1714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl Scudamore","raw_affiliation_strings":["2Exepathology, Devon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Exepathology, Devon, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051010078","display_name":"Bart Vanhaesebroeck","orcid":"https://orcid.org/0000-0002-7074-3673","observed_orcids":["https://orcid.org/0000-0002-7074-3673","https://orcid.org/0000-0001-5488-8322"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bart Vanhaesebroeck","raw_affiliation_strings":["3University College London Cancer Institute, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University College London Cancer Institute, London","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"7_Supplement","first_page":"5750","last_page":"5750"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3kdelta","display_name":"PI3K\u03b4","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pik3cd","display_name":"PIK3CD","score":0.9150000214576721},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6520000100135803},{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.7200000286102295},{"id":"https://openalex.org/keywords/crispr-cas9-deletion","display_name":"CRISPR/Cas9 gene deletion","score":0.8240000009536743},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6859999895095825},{"id":"https://openalex.org/keywords/pik3r1","display_name":"PIK3R1","score":0.722000002861023},{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.7319999933242798},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9290000200271606},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9139999747276306},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9369999766349792}],"concepts":[{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7408000230789185},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7192999720573425},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6218000054359436},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5108000040054321},{"id":"https://openalex.org/C6929976","wikidata":"https://www.wikidata.org/wiki/Q3771881","display_name":"Regulator","level":3,"score":0.49570000171661377},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4661000072956085},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4607999920845032},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4426000118255615},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4230000078678131},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.42289999127388},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41600000858306885},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.40529999136924744},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.4034000039100647},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.39969998598098755},{"id":"https://openalex.org/C189014844","wikidata":"https://www.wikidata.org/wiki/Q189118","display_name":"Cell type","level":3,"score":0.3626999855041504},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.3619999885559082},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3617999851703644},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3481000065803528},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.3395000100135803},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3368000090122223},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.320499986410141},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31949999928474426},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.31769999861717224},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.31150001287460327},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3034999966621399},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2913999855518341},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28029999136924744},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.27090001106262207},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.2662000060081482},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.26089999079704285},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25859999656677246},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.2540999948978424}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2026-5750","doi":"https://doi.org/10.1158/1538-7445.am2026-5750","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-5750","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8276569843292236,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"PI3K\u03b4":[1,28,61,81,85,163,201,211,228,242,266,284,316],"is":[2,29,63,107],"a":[3],"predominantly":[4],"leukocyte-enriched":[5],"class":[6],"I":[7],"PI3K":[8],"consisting":[9],"of":[10,33,41,97,158,198,210,223,272,315,320],"the":[11,21,39,89,92,175,196,208,217,270,280,321],"p110\u03b4":[12],"catalytic":[13],"subunit":[14,24],"(encoded":[15,25],"by":[16,26],"PIK3CD)":[17],"and":[18,36,117,124,141,184,206,230,257],"most":[19],"commonly":[20],"p85\u03b1":[22],"regulatory":[23],"PIK3R1).":[27],"an":[30,68,98],"important":[31],"regulator":[32],"B-cell":[34,47],"function":[35,200,314],"has":[37],"been":[38],"target":[40,88],"extensive":[42],"drug":[43],"development":[44],"efforts":[45],"for":[46,53,71,213,265,324],"malignancies,":[48],"with":[49,174,191],"multiple":[50,129],"inhibitors":[51,86,178,212,229],"approved":[52],"this":[54,171],"indication.":[55],"Based":[56],"on":[57],"our":[58],"pre-clinical":[59],"studies,":[60,259],"inhibition":[62,222,243],"now":[64],"also":[65,127,144],"emerging":[66],"as":[67],"immunotherapy":[69,214,292],"approach":[70],"solid":[72,130,204,235,268,281],"tumours.":[73],"Regulatory":[74],"T-cells":[75],"(Treg)":[76],"are":[77,187],"exquisitely":[78],"sensitive":[79],"to":[80,289],"inhibition,":[82],"therefore":[83],"pharmacological":[84],"preferentially":[87],"Tregs,":[90],"rebalancing":[91],"immune":[93,103],"system":[94],"in":[95,111,114,166,203,234,249,255,267],"favour":[96],"effector":[99],"T":[100],"cell-mediated":[101],"anti-tumour":[102],"response.":[104],"This":[105,194],"concept":[106],"currently":[108],"under":[109],"investigation":[110],"clinical":[112],"trials":[113],"uveal":[115],"melanoma":[116],"non-small":[118],"cell":[119,156,237,247],"lung":[120],"cancer.":[121],"Notably,":[122],"we":[123,239,260],"others":[125],"have":[126,261],"observed":[128],"tumour":[131,168,218,236,282],"types":[132,157],"including":[133],"glioblastoma,":[134],"melanoma,":[135],"breast":[136],"cancer,":[137,139],"prostate":[138],"neuroblastoma":[140],"hepatocellular":[142],"carcinoma":[143],"express":[145],"wild-type":[146],"PIK3CD,":[147],"often":[148],"at":[149,181],"much":[150],"higher":[151],"levels":[152],"than":[153],"their":[154],"non-transformed":[155],"origin.":[159],"Some":[160],"studies":[161],"suggest":[162,279],"promotes":[164],"proliferation":[165,248],"these":[167,185,250],"cells,":[169],"but":[170],"remains":[172],"unclear":[173],"potential":[176],"that":[177,241],"were":[179],"used":[180],"non-PI3K\u03b4-specific":[182],"concentrations,":[183],"findings":[186],"not":[188,245],"consistently":[189],"confirmed":[190],"genetic":[192],"approaches.":[193],"raises":[195],"questions":[197],"what":[199],"plays":[202],"tumours":[205],"how":[207],"use":[209],"will":[215,274],"affect":[216,246],"cells":[219],"themselves":[220],"via":[221],"cell-intrinsic":[224,283,313],"PI3K\u03b4.":[225],"Using":[226],"highly-selective":[227],"CRISPR-Cas9-mediated":[231],"PIK3CD":[232],"deletion":[233],"lines,":[238],"demonstrate":[240],"does":[244],"models.":[251],"However,":[252],"through":[253],"both":[254],"vitro":[256],"xenograft":[258],"identified":[262],"cancer-relevant":[263],"roles":[264],"tumours,":[269],"implications":[271],"which":[273],"be":[275,287],"presented.":[276],"Our":[277],"data":[278],"expression":[285],"should":[286],"considered":[288],"inform":[290],"PI3K\u03b4-targeting":[291],"studies.":[293],"Citation":[294],"Format:":[295],"Sarah":[296],"E.":[297],"Conduit,":[298],"Elena":[299],"Lopez-Guadamillas,":[300],"Daniele":[301],"Morelli,":[302],"Harriet":[303],"Howard,":[304],"Wayne":[305],"Pearce,":[306],"Cheryl":[307],"Scudamore,":[308],"Bart":[309],"Vanhaesebroeck.":[310],"Solid":[311],"tumor":[312],"[abstract].":[317],"In:":[318],"Proceedings":[319],"American":[322],"Association":[323],"Cancer":[325,343],"Research":[326],"Annual":[327],"Meeting":[328],"2026;":[329],"Part":[330],"1":[331],"(Regular":[332],"Abstracts);":[333],"2026":[334],"Apr":[335],"17-22;":[336],"San":[337],"Diego,":[338],"CA.":[339],"Philadelphia":[340],"(PA):":[341],"AACR;":[342],"Res":[344],"2026;86(7":[345],"Suppl):Abstract":[346],"nr":[347],"5750.":[348]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2026-04-04T00:00:00"}